What to expect in neurology in 2019 – Dr Andrew Evans

In 2019, neurologists can expect to see better neuroimaging techniques for stroke,  non-invasive treatments for Parkinsons’s disease, the first new class of drugs for migraine in many years, and re-purposing of old epilepsy drugs for improved outcomes in seizures. Speaking to the limbic, Dr Andrew Evans, head of the Movement Disorder Service at the Royal ...

Already a member?

Login to keep reading.

© 2022 the limbic